Skip to content

NEWGLAB Pharma

Metabolic Anti-Cancer Therapeutics

Menu

Home
Core Technology
Products
R & D
PR Center
- News
- Media
- Book
- Notice
Contact Us

Anticancer Therapeutics

You are here: NEWGLAB Pharma > Anticancer Therapeutics

Developing in process

United States

NEWGLAB PHARMA, INC.
Address: 701E. Pratt Street, Baltimore, MD 21202
Office: (+1) 443-887-4080
Lab: (+1) 443-887-4081
Fax: (+1) 410-234-8896
Email: contact@newglabpharma.com
Website: www.newglabpharma.com

Korea

NEWGLAB PHARMA KOREA Co., Ltd.
Address: 13F, 479, Bongeunsa-ro, Gungnam-gu, Seoul, Korea (06095)
Email: contact@newglabpharma.com
Website: www.newglabpharma.com

Recent News

Orphan drug designation (ODD) for “treatment of stage IIb-IV melanoma” by FDA
6 May 2020
Acquired ODD status and License-In for additional Indications
27 April 2020
Dietary supplement sales contract with KoDiscovery and Sales started in March
27 April 2020
Seminars with Georgia Medical Professionals
9 April 2020
Seminars about Anti- Bacteria Treatment using 3BP with the University of Wroclaw, Poland.
9 April 2020

Suggested Links

Original website
Kofactor store

Visitors Counter

51252

Copyright © 2020 NEWGLAB Pharma. Website made by Piotr Ulaszewski. Theme: Spacious by ThemeGrill.

Contact Us

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok